Quick Answer
Century Therapeutics, Inc. reported R&D Expense of $75.65 million for fiscal year 2021.
Century Therapeutics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $75.65M | +90.6% |
| 2020 | $39.68M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $19.55M | +80.8% | +3.2% |
| June 30, 2021 | $18.93M | +123.2% | +75.1% |
| September 30, 2020 | $10.81M | — | +27.4% |
| June 30, 2020 | $8.48M | — | — |
- Century Therapeutics, Inc. showed an increase of +90.6% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2021 period, Century Therapeutics, Inc.’s r&d expense has grown by 90.6% (from $39.68 million to $75.65 million).
- The most recent figure is from Century Therapeutics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 17, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: